Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip H Elsinga

Showing results (81-90 of 169) with videos related to

Pageof 17
Sort By:
Chemical Science|July 26, 2024
With or without a co-solvent? highly efficient ultrafast phenanthrenequinone-electron rich alkene (PQ-ERA) photoclick reactionsAnna M Doze, Youxin Fu, Mariangela Di Donato, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2009
Steroid hormones affect binding of the sigma ligand 11C-SA4503 in tumour cells and tumour-bearing ratsAnna A Rybczynska, Philip H Elsinga, Jurgen W Sijbesma, et al.
Nuclear Medicine and Biology|November 26, 2025
Integrating [<sup>11</sup>C]methylreboxetine PET and MRI to map in vivo norepinephrine transporter distribution: A proof-of-concept study of noradrenergic vulnerability in neurodegenerationJaime D Mondragon, Sofia Marcolini, Bruno Lima Giacobbo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 6, 2014
Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PETVladimir Shalgunov, Jan-Peter van Wieringen, Henk M Janssen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 20, 2020
Focused ultrasound for opening blood-brain barrier and drug delivery monitored with positron emission tomographyWejdan M Arif, Philip H Elsinga, Carmen Gasca-Salas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
Is 18F-3'-fluoro-3'-deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer?David C P Cobben, Philip H Elsinga, Harald J Hoekstra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2004
Tumor imaging with 2 sigma-receptor ligands, 18F-FE-SA5845 and 11C-SA4503: a feasibility studyAren van Waarde, Anne Rixt Buursma, Geke A P Hospers, et al.
EJNMMI Radiopharmacy and Chemistry|May 8, 2022
Potential PET tracers for imaging of tumor-associated macrophagesBruna Fernandes, Paula Kopschina Feltes, Carolina Luft, et al.
Medicinal Research Reviews|March 13, 2018
Avenues to molecular imaging of dying cells: Focus on cancerAnna A Rybczynska, Hendrikus H Boersma, Steven de Jong, et al.
EJNMMI Research|July 25, 2015
Synthesis and evaluation in rats of homologous series of [(18)F]-labeled dopamine D 2/3 receptor agonists based on the 2-aminomethylchroman scaffold as potential PET tracersVladimir Shalgunov, Jan-Peter van Wieringen, Henk M Janssen, et al.
Pageof 17

Showing results (81-90 of 169) with videos related to

Sort By:
Pageof 17
Chemical Science|July 26, 2024
With or without a co-solvent? highly efficient ultrafast phenanthrenequinone-electron rich alkene (PQ-ERA) photoclick reactionsAnna M Doze, Youxin Fu, Mariangela Di Donato, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2009
Steroid hormones affect binding of the sigma ligand 11C-SA4503 in tumour cells and tumour-bearing ratsAnna A Rybczynska, Philip H Elsinga, Jurgen W Sijbesma, et al.
Nuclear Medicine and Biology|November 26, 2025
Integrating [<sup>11</sup>C]methylreboxetine PET and MRI to map in vivo norepinephrine transporter distribution: A proof-of-concept study of noradrenergic vulnerability in neurodegenerationJaime D Mondragon, Sofia Marcolini, Bruno Lima Giacobbo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 6, 2014
Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PETVladimir Shalgunov, Jan-Peter van Wieringen, Henk M Janssen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 20, 2020
Focused ultrasound for opening blood-brain barrier and drug delivery monitored with positron emission tomographyWejdan M Arif, Philip H Elsinga, Carmen Gasca-Salas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
Is 18F-3'-fluoro-3'-deoxy-L-thymidine useful for the staging and restaging of non-small cell lung cancer?David C P Cobben, Philip H Elsinga, Harald J Hoekstra, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2004
Tumor imaging with 2 sigma-receptor ligands, 18F-FE-SA5845 and 11C-SA4503: a feasibility studyAren van Waarde, Anne Rixt Buursma, Geke A P Hospers, et al.
EJNMMI Radiopharmacy and Chemistry|May 8, 2022
Potential PET tracers for imaging of tumor-associated macrophagesBruna Fernandes, Paula Kopschina Feltes, Carolina Luft, et al.
Medicinal Research Reviews|March 13, 2018
Avenues to molecular imaging of dying cells: Focus on cancerAnna A Rybczynska, Hendrikus H Boersma, Steven de Jong, et al.
EJNMMI Research|July 25, 2015
Synthesis and evaluation in rats of homologous series of [(18)F]-labeled dopamine D 2/3 receptor agonists based on the 2-aminomethylchroman scaffold as potential PET tracersVladimir Shalgunov, Jan-Peter van Wieringen, Henk M Janssen, et al.
Pageof 17